Stock Watch: Unnatural Selection In Clinical Trials
Have We Been Doing It Wrong All These Years?
Executive Summary
Patient selection is held out as the Achilles heel of clinical trial success. But a surprise and fortunate finding in Pfizer’s gene therapy trial has already resulted in tightened recruitment criteria, thanks to genetic analysis.